NEWS and OPINIONS
World Stem Cell Summit 2018 in Miami Solidifies Regenerative Medicine as the Future of Healthcare
Miami, FL – January 30, 2017 – The international regenerative medicine community concluded a week sharing breakthroughs, facing challenges and developing collaborations at the 13th World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-26, 2018. The...
Joe and Jill Biden among several honored at World Stem Cell Summit gala
By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI - January 25, 2018 - Greg Simon, president of the Biden Cancer Initiative gives an acceptance speech on behalf of the Bidens. Former Vice President Joe Biden and Dr. Jill Biden were...
Interview: Dr. Anthony Atala discusses the future of regenerative medicine
By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 - Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine and the W.H. Boyce professor and chair of the Department of Urology at Wake...
Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami
MIAMI, Jan. 22, 2018 /PRNewswire/ -- Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company's hometown of Miami for the 2018 World Stem Cell Summit, January...
Aging Frailty with Influenza Vaccine Trial announced by Longeveron
America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
Longeveron Alzheimer’s Disease Trial
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
Longeveron Aging Frailty Phase 2b Trial
Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...
Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit
PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired - January 21, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D.,...
Mayo Clinic Center for Regenerative Medicine at the 2018 World Stem Cell Summit
The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the 13th annual event Jan. 22-26 in Miami, Florida. Researchers and clinical experts from Mayo Clinic will participate in...
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
Posted: January 18, 2018 January 18, 2018 - Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease - a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a...
The Making of a Stem Cell Super-Ecosystem with Bernard Siegel
January 17, 2018 By Cade Hildreth (CEO) Leave a Comment I am honored to share this interview with Bernard Siegel, Executive Director of the Regenerative Medicine Foundation (RMF), a global network of stakeholders that fosters collaboration across the industry. Bernard...
Pioneers of Hope: Patient Advocate Doug Oliver’s Interview of Dr. Francis Collins, Director, National Institutes of Health (NIH)
The Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with leading influencers in the Regenerative Medicine movement. These articles are our way of sharing the hope that this field...